{"hq_id":"hq-c-org-001958","name":"Tylosin","context":"human_adult","timestamp":"2026-08-28T02:44:31.001Z","risk_level":"low","risk_profile":{"magnitude":{"mean":0.2,"weightedMean":0.2,"std_dev":0,"confidence_interval_95":[0.2,0.2],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.2,"weight":0.35}]},"confidence":{"mean":0.5,"weightedMean":0.5,"std_dev":0,"confidence_interval_95":[0.5,0.5],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.5,"weight":0.35}]},"recency":{"mean":1,"weightedMean":1,"std_dev":0,"confidence_interval_95":[1,1],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":1,"weight":0.35}]},"methodology":{"mean":0.7,"weightedMean":0.7,"std_dev":0,"confidence_interval_95":[0.7,0.7],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.7,"weight":0.35}]},"specificity":{"mean":0.92,"weightedMean":0.92,"std_dev":0,"confidence_interval_95":[0.92,0.92],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.92,"weight":0.35}]},"consensus":{"exists":false,"strength":0,"disagreement_magnitude":0,"warning":"single_source_warning"}},"interpretation":{"summary":"Single source (HQ_DIRECT, 2026) indicates low risk.","confidence_note":"Evidence quality varies; interpretation requires caution.","context_note":null,"warning":"single_source_warning"},"sources":[{"id":"fda_tylosin_nada_label","type":"regulatory","title":"FDA NADA Tylosin (Tylan) — veterinary label, beef/swine/poultry indications","year":2017},{"id":"who_hpcia_macrolides_2019","type":"regulatory","title":"WHO List of Critically Important Antimicrobials for Human Medicine (HPCIA, 6th rev) — macrolides highest-priority","year":2019},{"id":"fda_gfi_213_animal_antibiotics_2017","type":"regulatory","title":"FDA Guidance for Industry #213 — Medically Important Antibiotics in Food Animals (VFD)","year":2017},{"id":"codex_alimentarius_tylosin_mrl","type":"regulatory","title":"Codex Alimentarius Maximum Residue Limits — Tylosin (food animals)","year":2023},{"id":"ecdc_amr_macrolides","type":"regulatory","title":"ECDC AMR Surveillance — macrolide-resistance trends","year":2023}],"sources_scope":"record","warnings":["unmapped_classification:FDA:approved veterinary drug (multiple nadas)","unmapped_classification:WHO:critically important antimicrobial — macrolide cla","single_source_warning"],"meta":{"synthesis_version":"1.1.0","config_version":"1.1.0","n_sources":1,"db_version":7,"warnings":["unmapped_classification:FDA:approved veterinary drug (multiple nadas)","unmapped_classification:WHO:critically important antimicrobial — macrolide cla"]},"schema":"synthesis","_notice":"ALETHEIA output is reference data, not professional advice. Not a substitute for primary agency sources or qualified professionals. See https://aletheia.holisticquality.io/disclaimer.","_disclaimer_url":"https://aletheia.holisticquality.io/disclaimer","available_contexts":["human_adult","dog","cat","human_teen","human_elderly","human_pregnant","exposure_dermal","exposure_inhalation","exposure_ingestion","exposure_ocular","occupational_exposure"]}